Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

29.16
Delayed Data
As of Feb 17
 +0.40 / +1.39%
Today’s Change
25.55
Today|||52-Week Range
35.04
+6.73%
Year-to-Date
AZN Regular Dividend: AZN began trading ex-dividend on 02/15/17. A $0.95 dividend will be paid to shareholders of record as of 02/17/17.

Today’s Trading

Previous close28.76
Today’s open29.16
Day’s range28.94 - 29.27
Volume4,496,430
Average volume (3 months)7,280,827
Market cap$73.8B
Dividend yield4.80%
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+23.59%
Earnings growth (this year)-13.49%
Earnings growth (next 5 years)+2.30%
Revenue growth (last year)-7.37%
P/E ratio30.1
Price/Sales3.03
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.49+1.11%
NVONovo Nordisk+0.02+0.06%
LLYEli Lilly and Co+0.35+0.44%
BMYBristol-Myers Squibb+0.31+0.57%
Data as of 5:17pm ET, 02/17/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.43
Annual revenue (last year)$22.8B
Annual profit (last year)$3.5B
Net profit margin15.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts


Search for Jobs